Literature DB >> 9544643

Digital subtraction indocyanine green angiography of occult choroidal neovascularization.

R F Spaide1, D Orlock, L Yannuzzi, M Ruff, Y Fisher, D Guyer, J Slakter, J Sorenson.   

Abstract

OBJECTIVE: This study aimed to use a new technique for ocular imaging, digital subtraction indocyanine green angiography (DS-ICGA), to evaluate patients with occult choroidal neovascularization (CNV).
DESIGN: The design was a cross-sectional study of patients with occult CNV. PARTICIPANTS: A total of 31 eyes of 31 patients were studied. INTERVENTION: Digital subtraction of sequentially acquired indocyanine green angiographic frames was used to image the progression of the dye front in eyes with occult CNV. A method of pseudocolor imaging of the choroid was developed that allows differentiation and identification of underlying choroidal arteries and veins.
RESULTS: The DS-ICGA of occult CNV showed consistent findings. Occult CNV was imaged with greater detail and in a shorter period of time than with conventional indocyanine green angiography. The fundus landmarks were retained with DS-ICGA much better than with conventional indocyanine green angiography.
CONCLUSIONS: The DS-ICGA uses time to dissect the choroidal circulation. With DS-ICGA, occult CNV could be imaged more quickly and in greater detail than with conventional imaging techniques. The DS-ICGA may improve the authors ability to image, and subsequently treat, occult CNV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544643     DOI: 10.1016/S0161-6420(98)94024-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  1 in total

1.  Correlation of choriocapillaris hemodynamic data from dynamic indocyanine green and optical coherence tomography angiography.

Authors:  Chui Ming Gemmy Cheung; Kelvin Yi Chong Teo; Sai Bo Bo Tun; Joanna Marie Busoy; Veluchamy A Barathi; Richard F Spaide
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.